Investor Stock List
Ranked #7,442 of 8,699 institutional investors

22nw, LP

Seattle, WA

$134M
US stock portfolio at live prices · today −$4.4M (−3.16%)
Market closed. Prices as of Nov 20, 6:41 AM ET
Value at quarter end (Q3 2026)
$144M
Change from Q2 2026
+$39.6M (+37.86%)
Positions
14 · 3 new, 3 sold out
Filed
Nov 13, 2026

Not counted in the ranking: none$13.2M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
NSP 17.4%TBCH 15.4%RYZ 10.2%FOXF 8.56%SRI 8.14%
StockSharesValue, live% of portfoliovs Q2 2026
NSP Insperity, Inc.493,000$23.3M17.4%Unchanged
TBCH Turtle Beach Corporation1,304,878$20.6M15.4%Added +8,943%
RYZ Ryerson Holding Corporation488,356$13.6M10.2%New
FOXF Fox Factory Holding Corp.678,165$11.5M8.56%Unchanged
SRI Stoneridge, Inc.2,466,975$10.9M8.14%Unchanged
NKTR Nektar Therapeutics281,115$9.1M6.83%Unchanged
CMT Core Molding Technologies, Inc.345,291$7.5M5.64%Added +26%
WD Walker & Dunlop, Inc.172,071$6.9M5.15%New
CULP Culp, Inc.1,859,061$5.9M4.40%Unchanged
UFI Unifi, Inc.849,955$4.8M3.57%Reduced −0%
TISI Team, Inc.170,187$4.2M3.15%Unchanged
ELDN Eledon Pharmaceuticals, Inc.636,364$1.2M0.90%Unchanged
BLND Blend Labs, Inc.1,239,875$1.1M0.82%New
LFCR Lifecore Biomedical, Inc.1,254$8K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
RGNX REGENXBIO Inc.492,759$3.5M
RZLT Rezolute, Inc.820,653$3.4M
MLYS Mineralys Therapeutics, Inc.113,840$1.6M